HilleVax Pre-IPO: Lead Candidate Has Potential to Become First Approved Vaccine for Norovirus
Norovirus vaccine developer, Hillevax, formed by Takeda Pharmaceutical and PE firm Frazier Healthcare Partners, is seeking to raise up to $100...
No more insights